New drug aims to tame dangerous inflammation in kidney patients
Disease control
Completed
This study tested a new drug, TOUR006, designed to lower a key marker of inflammation (hs-CRP) in people with chronic kidney disease. Researchers wanted to see if giving the drug monthly or quarterly was safe and effective at reducing this inflammation. The goal is to see if cont…
Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC